MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Development"

  • 2022 International Congress

    Improvement of movement disorder and neurodevelopment under selegiline in a CLTC deficient patient

    F. Nardecchia, L. Pannone, F. Manti, V. Muto, R. Bove, L. Pollini, M. Giannini, M. Tartaglia, S. Martinelli, V. Leuzzi (Rome, Italy)

    Objective: We report the significative improvement on both movement disorder and neurodevelopment in a 5-year-old CLTC deficient patient treated with selegiline. Background: In 2019 we described a 30-year-old woman…
  • MDS Virtual Congress 2021

    Combined Plantar Stimulations Using a Novel Parkinson Shoe benefit Parkinson’s Disease Patients with Unresponsive Freezing of Gait

    W. Phuenpathom, P. Panyakaew, S. Fungtammasan, P. Vateekul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the effect of combined vibratory and pressure stimulations in PD patients with unresponsive FOG and develop the innovative PD shoe. Background: Freezing…
  • MDS Virtual Congress 2021

    Prognostic Modeling of Parkinson’s Disease Progression Using Early Longitudinal Patterns of Change

    X. Ren, J. Lin, G. Stebbins, C. Goetz, S. Luo (Foster City, CA, USA)

    Objective: To develop a prognostic model using multiple longitudinal measures to predict temporal clinical progression in early PD. Background: Predicting time to Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Parkinsonism in individuals with genetic neurodevelopmental disorders: A systematic review

    E. Scheibler, M. Kuijf, T. Koning, J. Zinkstok, A. Muller, T. Amelsvoort, A. Eeghen, E. Boot (Amersfoort, Netherlands)

    Objective: It is increasingly recognized that individuals with genetic neurodevelopmental disorders (GNDs) such as 22q11.2 deletion syndrome can suffer from parkinsonism. We aim to provide…
  • MDS Virtual Congress 2021

    DAT-IQ improves power to detect longitudinal change in DaT deficit in SURE-PD3

    Z. Fan, J. Seibyl, K. Marek, M. Schwarzschild, E. Macklin, R. Gunn (London, United Kingdom)

    Objective: DATIQ has been developed as a novel analytical approach to improve the sensitivity and statistical efficiency of dopamine transporter (DaT) SPECT quantification over previously…
  • MDS Virtual Congress 2021

    Freezing of gait in Parkinson’s disease: A 4-item FOG-Quick questionnaire assessment

    W. Phuenpathom, O. Phokaewvarangkul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To translate and validate a Thai language version of the FOG-Q. In addition, to develop a short-version 4-item question or FOG-Quick questionnaire was developed.…
  • MDS Virtual Congress 2020

    Early life stress offers a window into the relationship between depression and Parkinson’s disease: A 60-week study after maternal separation in rats

    C. Ren, K.J He, Y.T Zhang, J.B Zhang, F. Wang, C.F Liu (Suzhou, China)

    Objective: The aim of this study was to examine the relationship between depression and Parkinson's disease (PD) using the rat model of maternal separation (MS).…
  • MDS Virtual Congress 2020

    The Personalized Parkinson Project – data quality enhancing strategies

    B. Bloem, L. Evers, T. vande Zande, R. Kapur, M. Meinders, W. Marks, Jr (Nijmegen, Netherlands)

    Objective: Demonstrate the impact of quality enhancing strategies in the Personalized Parkinson Project. Background: Increasingly, the scientific community uses data from longitudinal observational patient cohorts…
  • MDS Virtual Congress 2020

    Clinical outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency (PTPSd)

    F. Nardecchia, F. Manti, S. Galosi, A. Burlina, D. Gueraldi, M. Donati, F. Pochiero, a. Cassio, F. Porta, M. Spada, C. Carducci, C. Carducci, S. Paci, G. Banderali, M. Schiaffino, N. Blau, V. Leuzzi (Rome, Italy)

    Objective: To assess morbility and clinical outcome of patients affected by defect of tetrahydrobiopterin (BH4) synthesis due to PTPSd. Background: PTPSd is a treatable genetic disorder…
  • MDS Virtual Congress 2020

    Loss‐of‐function mutations in NR4A2 cause dopa‐responsive dystonia-parkinsonism

    T. Wirth, LL. Mariani, G. Bergant, M. Baulac, M.O Habert, N. Drouot, E. Ollivier, A. Hodžic, G.o Rudolf, P. Nitschke, G.a Rudolf, J. Chelly, C. Tranchant, M. Anheim, E. Roze (London, United Kingdom)

    Objective: To report two patients with early-onset dystonia-parkinsonism as a result of loss-of-function mutations in nuclear receptor subfamily 4 group A member 2 (NR4A2). Background:…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley